New York State Common Retirement Fund Cogent Biosciences, Inc. Transaction History

New York State Common Retirement Fund

$74.9 Billion
Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 33,902 shares of COGT stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,902

Previous 23,102 46.75%

Holding current value

$1.14 Million

Previous $165,000 194.55%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	BUY	$7.17 - $14.36 $77,436 - $155,088	10,800 Added 46.75%	33,902 $486,000
Q4 2024 Oct 08, 2025	BUY	$7.64 - $12.28 $16,808 - $27,016	2,200 Added 10.53%	23,102 $180,000
Q4 2024 Jan 31, 2025	BUY	$7.64 - $12.28 $16,808 - $27,016	2,200 Added 10.53%	23,102 $180,000
Q3 2024 Oct 08, 2025	SELL	$8.24 - $11.48 $18,128 - $25,256	-2,200 Reduced 9.52%	20,902 $225,000
Q3 2024 Oct 28, 2024	SELL	$8.24 - $11.48 $74,160 - $103,320	-9,000 Reduced 30.1%	20,902 $226,000

Q2 2024 Oct 08, 2025	BUY	$6.01 - $9.04 $40,868 - $61,471	6,800 Added 29.43%	29,902 $252,000
Q2 2024 Jul 31, 2024	SELL	$6.01 - $9.04 $24,154 - $36,331	-4,019 Reduced 11.85%	29,902 $252,000
Q1 2024 Oct 08, 2025	BUY	$4.38 - $9.02 $47,387 - $97,587	10,819 Added 46.83%	33,921 $227,000
Q1 2024 May 07, 2024	BUY	$4.38 - $9.02 $58,516 - $120,507	13,360 Added 64.98%	33,921 $228,000
Q4 2023 Oct 08, 2025	SELL	$4.06 - $10.08 $10,316 - $25,613	-2,541 Reduced 11.0%	20,561 $120,000
Q4 2023 Feb 01, 2024	SELL	$4.06 - $10.08 $50,315 - $124,921	-12,393 Reduced 37.61%	20,561 $121,000
Q3 2023 Oct 08, 2025	BUY	$9.69 - $13.34 $95,465 - $131,425	9,852 Added 42.65%	32,954 $321,000
Q3 2023 Nov 07, 2023	BUY	$9.69 - $13.34 $104,361 - $143,671	10,770 Added 48.55%	32,954 $321,000
Q2 2023 Oct 08, 2025	SELL	$9.85 - $13.24 $9,042 - $12,154	-918 Reduced 3.97%	22,184 $262,000
Q2 2023 Aug 07, 2023	SELL	$9.85 - $13.24 $93,131 - $125,184	-9,455 Reduced 29.88%	22,184 $263,000
Q1 2023 Oct 08, 2025	SELL	$10.04 - $15.5 $144,837 - $223,603	-14,426 Reduced 31.32%	31,639 $341,000
Q1 2023 May 02, 2023	SELL	$10.04 - $15.5 $144,837 - $223,603	-14,426 Reduced 31.32%	31,639 $341,000
Q4 2022 Oct 08, 2025	BUY	$10.65 - $14.84 $244,555 - $340,770	22,963 Added 99.4%	46,065 $532,000
Q4 2022 Jan 30, 2023	BUY	$10.65 - $14.84 $41,992 - $58,514	3,943 Added 9.36%	46,065 $533,000
Q3 2022 Nov 08, 2022	BUY	$9.39 - $16.99 $156,503 - $283,172	16,667 Added 65.48%	42,122 $628,000
Q2 2022 Aug 04, 2022	SELL	$3.92 - $9.73 $352 - $875	-90 Reduced 0.35%	25,455 $230,000
Q1 2022 May 05, 2022	BUY	$5.31 - $8.7 $207 - $339	39 Added 0.15%	25,545 $191,000
Q4 2021 Feb 02, 2022	SELL	$7.51 - $10.81 $593 - $853	-79 Reduced 0.31%	25,506 $219,000
Q3 2021 Nov 02, 2021	SELL	$5.99 - $9.14 $37,227 - $56,805	-6,215 Reduced 19.54%	25,585 $215,000
Q2 2021 Aug 02, 2021	BUY	$7.82 - $9.3 $248,676 - $295,740	31,800 New	31,800 $258,000

Others Institutions Holding COGT

# of Institutions

216

Shares Held

133M

Call Options Held

999K

Put Options Held

429K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $2.21B
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Cogent Biosciences, Inc. Transaction History